BiotechTube
Home/Perception Neuroscience/Mouhannad Jumaa, PhD
MJ

Mouhannad Jumaa, PhD

Chief Executive Officer

Perception Neuroscience

Therapeutic Areas

PsychiatryNeuroscience

Perception Neuroscience Pipeline

DrugIndicationPhase
PCN-101 (R-ketamine)Treatment-Resistant DepressionPhase 2a